Key Takeaways
- Medication adherence is a matter of survival in pediatric cancer, not convenience. In childhood leukemia, adherence to oral chemotherapy below 95% is associated with a roughly threefold higher risk of relapse, yet a landmark trial found that nearly half of young patients fell below that threshold. This is one of the highest-stakes adherence problems in all of medicine.
- Gamification can genuinely help, and there is real clinical evidence for it, including a multicenter randomized trial of a cancer video game that improved chemotherapy adherence measured by blood tests, not self-report. But the same psychological levers that make games motivating are the levers that dark patterns exploit, and children are uniquely vulnerable to that manipulation.
- The entire design challenge is drawing a bright line between engagement that serves the child and mechanics that exploit them. The distinction is not aesthetic, it is ethical and psychological, and it maps cleanly onto whether the design supports a child’s autonomy, competence, and connection or hijacks their impulses for engagement metrics.
When Adherence Is a Matter of Life and Death
In most of digital health, medication adherence is framed as a problem of convenience and gentle nudging. A patient forgets a pill, an app reminds them, outcomes improve at the margins. Pediatric oncology is not like that. Here, adherence is not a matter of optimizing a chronic-care metric. It is a matter of whether a child relapses.
The clearest evidence comes from acute lymphoblastic leukemia, or ALL, the most common childhood cancer. Treatment includes a long maintenance phase, often 18 to 30 months, during which the child takes a daily oral chemotherapy drug called 6-mercaptopurine at home. The stakes of taking it consistently are stark. A Children’s Oncology Group study published in JAMA Oncology found that adherence below 95% was associated with a 2.7-fold higher risk of relapse compared to children who stayed at or above that threshold. That is not a typo. Missing more than one dose in twenty is enough to measurably raise the odds that a child’s cancer comes back.
And missing doses is common. The same body of research found that a striking share of young patients do not reach that critical threshold. In one Children’s Oncology Group trial using electronic monitoring devices, 44% of patients had adherence rates under 95%, which is precisely the level associated with elevated relapse risk. Across the broader literature, reported nonadherence in children with ALL ranges widely, from as low as a few percent to more than half, depending on how it is measured. The problem is real, it is prevalent, and it has life-or-death consequences.
The reasons behind it are deeply human, especially for adolescents and young adults, who consistently show lower adherence than younger children. A maintenance regimen asks a teenager who feels basically well, because they are in remission, to keep taking a drug with unpleasant side effects every single day for years. That demand runs directly against the normal developmental drives of adolescence: establishing independence, resisting authority, and living in the present rather than the abstract future. Layer on the executive-function challenges of remembering a daily task, the fatigue of long treatment, and the emotional weight of cancer, and it becomes clear why adherence falters. This is not a failure of willpower. It is a mismatch between a rigid medical demand and the realities of a developing young person’s life.
This is exactly the kind of behavioral problem that thoughtful software can address, and it is why gamification has drawn serious clinical interest in pediatric oncology. If a daily pill can be woven into an experience a child actually wants to engage with, adherence can improve, and in this context, improving adherence can save lives. But that promise comes with an equally serious ethical obligation, because the population is uniquely vulnerable and the same design techniques that motivate can also manipulate. In this post, we will walk through the clinical case for gamified adherence, the real evidence that it works, the psychology that separates ethical engagement from exploitation, and how to design a pediatric oncology app that helps children without preying on them.
The Evidence That Gamification Can Work
Before designing anything, it is worth grounding the discussion in what the evidence actually shows, because gamification is often oversold, and honesty about the data is what separates a credible product from hype.
The broad picture is genuinely promising but appropriately nuanced. Multiple systematic reviews have found that medication-adherence apps using gamification elements improve adherence across a range of chronic conditions, and that gamified digital health interventions can outperform non-gamified ones for certain behaviors. At the same time, the research is candid about its limits.
One frequently cited systematic review of gamification for health and wellbeing found that while 59% of studies reported positive effects, 41% showed mixed or neutral findings, with mostly moderate or lower quality of evidence, which means gamification is not a guaranteed win. Much of the existing evidence is also short-term, measured over weeks or a few months, leaving real questions about long-term sustainability. The honest takeaway is that gamification is a powerful tool that works when it is designed well and grounded in behavioral theory, and falls flat when it is bolted on as a superficial layer of points and badges.
The most compelling evidence in this specific domain comes from a game built expressly for young cancer patients. Re-Mission, developed by the nonprofit HopeLab, is a video game in which players pilot a nanobot named Roxxi through the bodies of fictional cancer patients, destroying cancer cells and managing treatment side effects. It was not a casual entertainment product.
It was designed to teach young patients why sticking to their treatment matters. To test it, HopeLab ran a serious study: a randomized controlled trial enrolling 375 patients aged 13 to 29 across 34 medical centers in the United States, Canada, and Australia, with results published in the journal Pediatrics.
What makes the Re-Mission trial especially credible is how it measured success. Rather than relying on patients to self-report whether they took their medication, which is notoriously unreliable, the researchers used objective measures: blood tests to detect chemotherapy levels in patients’ bodies and electronic pill-cap monitors to track antibiotic use. Measured this way, playing Re-Mission led to significantly improved treatment adherence and greater gains in cancer-related self-efficacy and knowledge in young cancer patients.
Notably, the trial found this effect on the objective adherence measures even though self-reported adherence did not change, which is a strong signal that something real was happening beneath what patients themselves reported. A later brain-imaging study helped explain why: active gameplay activated reward-related circuits in the brain in a way that passively watching the same content did not, sparking the positive motivation that helped shift attitudes toward treatment. HopeLab went on to distribute the game to well over a hundred thousand patients in dozens of countries.
The lesson from Re-Mission is not “add a game and adherence improves.” It is subtler and more important. The game worked because it was purpose-built around the psychology of its young patients, co-created with input from more than a hundred of them, and designed to build genuine understanding and self-efficacy rather than to merely rack up engagement. That distinction, between gamification that builds a child up and gamification that simply hooks them, is the heart of this entire topic.
Why Exploitative Mechanics Are a Special Danger for Children
Here is the uncomfortable truth at the center of this subject. The psychological techniques that make games engaging are the same techniques that, turned in a different direction, become manipulative. And when the users are children, and specifically sick children, the ethical stakes of that dual-use reality could not be higher.
The manipulative versions of these techniques have a name: dark patterns. The term, coined by UX specialist Harry Brignull, describes design tricks that manipulate users into choices they would not otherwise have made if they understood the situation or had a real choice. In games, researchers have catalogued dark patterns across several categories: temporal patterns like artificial grinding that makes a free experience deliberately tedious, monetary patterns that obscure real costs, social patterns that pressure users through their relationships, and psychological patterns that exploit cognitive biases and emotional states. T
hese are not fringe concerns. Researchers have documented these manipulative mechanics across the games industry, and regulators have taken direct action against them. The Federal Trade Commission levied a $245 million penalty against the maker of Fortnite over interface designs that tricked players, including children, into unwanted purchases, and its 2022 staff report on dark patterns flagged children’s apps as a specific area of concern.
Children are not simply small adults when it comes to this manipulation. They are meaningfully more vulnerable, and the reasons are developmental. Child-advocacy groups petitioning the FTC have emphasized that children have immature and developing executive functioning, which leads to impulsive behavior that dark patterns are engineered to exploit. Their still-developing abstract thinking makes it hard to understand things like the arbitrary value of in-game currencies or the real motives behind a design.
Their strong need for peer acceptance makes social-pressure mechanics especially potent. In short, the exact cognitive and emotional traits that define childhood are the traits that manipulative design targets. Regulators have taken note, and dark patterns are now addressed under major privacy laws such as the California Privacy Rights Act.
Now place that reality in the context of pediatric oncology, and the ethical obligation becomes overwhelming. The users are children who are seriously ill, often frightened, sometimes in pain, and emotionally vulnerable in ways healthy children are not. To deploy engagement-maximizing dark patterns against such a population, even in the name of adherence, would be a profound violation of the trust that families place in a medical tool.
It would also be self-defeating, as we will see, because manipulative mechanics tend to produce brittle short-term compliance rather than the durable behavior change that actually protects a child’s health. The imperative here is not merely to avoid the worst abuses. It is to design from a foundation of genuine respect for the child.
This is a principle that responsible development teams take seriously. The best guidance on gamification and user engagement is explicit that gamification which manipulates vulnerable users or fosters unhealthy, addictive behaviors raises serious ethical issues, and that responsible gamification instead offers users genuine choice and balance in how much they engage. In pediatric oncology, that principle is not a nice-to-have. It is the entire ballgame.
The Ethical Compass: Self-Determination Theory
To design gamification that helps rather than exploits, teams need more than good intentions. They need a principled framework for telling the two apart, and the most useful one comes from decades of motivation research: Self-Determination Theory.
Self-Determination Theory, developed by psychologists Edward Deci and Richard Ryan, holds that humans have three basic psychological needs, and that satisfying them produces intrinsic, self-sustaining motivation. The three needs are autonomy, the sense of acting by one’s own choice; competence, the sense of growing capable and effective; and relatedness, the sense of connection to others. This framework matters enormously for gamification because it draws a clean line between two fundamentally different kinds of design. Game mechanics can be built to satisfy these needs and cultivate a child’s own motivation, or they can be built to bypass them and coerce behavior from the outside.
The distinction is not abstract. It has concrete, observable consequences. Design that supports autonomy, competence, and relatedness tends to produce durable, internalized motivation that persists over time. Design that relies on external pressure produces something weaker and more fragile.
As motivation researchers describe it, extrinsically motivated activity done for an outcome separable from the task itself, such as rewards or punishments, thwarts the need for autonomy and gives rise to feelings of tension and coercion, while design that satisfies the underlying psychological needs produces motivation that is both more sustained and better for wellbeing. For a condition requiring years of daily adherence, durability is everything. A mechanic that works for two weeks and then curdles into resentment is worse than useless.
Self-Determination Theory also illuminates a specific and counterintuitive hazard: the overjustification effect. A large body of research, including a well-known meta-analysis by Deci, Koestner, and Ryan, has found that tangible, expected rewards can actually undermine intrinsic motivation for an already interesting activity, by shifting a person’s perceived reason for acting from internal (“I am doing this to get better”) to external (“I am doing this to earn the prize”).
This means that a poorly designed reward system can paradoxically make a child less internally motivated to take their medication over the long run, even if it boosts compliance briefly. The implication for pediatric oncology is profound. The goal is not to make a child dependent on the app’s rewards to take a life-saving drug. The goal is to help the child build their own durable commitment to their health, with the app as a supportive scaffold that can eventually fade. Self-Determination Theory is the compass that keeps design pointed at that goal, and it is the practical test for whether a given mechanic serves the child or exploits them.
Designing Ethical Gamification: Principles That Serve the Child
With that framework in hand, here is how the principles translate into concrete design decisions. Each of these maps back to supporting a child’s genuine motivation rather than hijacking their impulses.
Support Autonomy, Never Coerce
Autonomy-supportive design gives the child meaningful choice and a sense of ownership. That might mean letting them choose and customize an avatar or companion character, select from different ways to engage, or set their own goals within safe clinical bounds. Crucially, it means avoiding coercive mechanics that punish or shame. The difference between “Great job, you took your medicine, here is what happens next in your story” and “You broke your 14-day streak, you have lost your progress” is the difference between supporting a child and manipulating them through loss aversion and guilt. The first respects the child as an agent in their own care. The second treats them as a behavior to be conditioned. In a pediatric context, streak-loss mechanics and other punitive pressure tactics have no place, because they trade a child’s emotional wellbeing for a compliance metric.
Build Competence Through Meaningful Progression
Competence-supportive design helps the child feel themselves growing more capable and knowledgeable. This is where gamification and genuine health education can reinforce each other beautifully. A well-designed progression can teach a child, in age-appropriate ways, what their medication does and why it matters, building the self-efficacy that Re-Mission demonstrated was so valuable. Progress visualizations, achievable milestones, and a difficulty curve calibrated to feel rewarding rather than trivial or frustrating all serve this need. The point is not to make the child feel they have beaten a game, but to help them feel they are becoming someone who understands and manages their own health, a sense of mastery that can outlast the app itself.
Foster Genuine Relatedness
Relatedness-supportive design connects the child to people who matter, which in this context often means their care team and family rather than an anonymous competitive leaderboard. Features that let a parent share in a child’s progress, that celebrate milestones with the clinical team, or that connect a child to a moderated, safe community of peers facing similar challenges can satisfy the need for connection in a healthy way. This stands in deliberate contrast to the social dark patterns that exploit children’s need for peer approval through competitive pressure or fear of missing out. The distinction is whether the social features nourish real, supportive relationships or manufacture anxiety to drive engagement.
Make Rewards Meaningful, Not Manipulative
Given the overjustification hazard, rewards require particular care. The safest and most effective rewards tend to be those tied to the intrinsic narrative and the child’s sense of progress rather than escalating extrinsic prizes designed to create compulsion. Celebrating an achievement within a story the child is invested in, unlocking the next chapter of a narrative, or marking genuine health milestones supports motivation without the risks of a variable-reward slot-machine mechanic. The design goal is to reinforce the child’s own reasons for taking their medication, not to substitute the app’s reward schedule for those reasons. Any mechanic that starts to resemble the compulsion loops of exploitative games is a signal to stop and redesign.
Keep the Clinical Purpose Central
Finally, the gamification must always serve the medical goal rather than overshadow it. Responsible design ensures game elements support the app’s primary purpose rather than dominating the experience, and rebalances them whenever they begin to obstruct the actual function. In a pediatric oncology app, that function is helping a child adhere to a treatment that protects their life. Every mechanic should be evaluated against that purpose. If a feature is driving engagement but not advancing adherence, understanding, or the child’s wellbeing, it is decoration at best and a distraction at worst. The discipline of keeping the clinical goal central is what separates a legitimate medical tool from an engagement product wearing a medical costume.
The Technical and Compliance Foundation
Ethical gamification sits atop a technical and regulatory foundation that, for a pediatric oncology app, is unusually demanding. Getting the design philosophy right does not excuse getting the engineering and compliance wrong.
Because the app handles the health information of children, it operates under two overlapping regimes of heightened protection. Any app dealing with protected health information must be built for HIPAA-compliant handling of sensitive medical data, meaning encryption in transit and at rest, strong authentication, role-based access controls, and thorough audit logging. On top of that, because the users are children, the app falls under the Children’s Online Privacy Protection Act, COPPA, which imposes strict requirements around parental consent and the collection and handling of data from children under 13. Data minimization is not just good practice here but a legal and ethical necessity, and the app should collect only what the clinical purpose genuinely requires.
The involvement of caregivers is both a compliance requirement and a design opportunity. Parents and guardians are central to a young child’s treatment, and the app should be built to include them, through parental controls, shared visibility into the child’s progress, and features that support rather than bypass the family’s role in care. This is one area where the interests of compliance, ethics, and effectiveness all align, since caregiver involvement improves adherence and satisfies the relatedness need at the same time.
If the app moves beyond general wellness and adherence support into functions intended to diagnose, treat, or actively manage the cancer itself, it may enter the territory of a regulated medical device app, with the FDA oversight and Software as a Medical Device obligations that entails. Where the app aims to function as a genuine therapeutic rather than a supportive tool, the discipline of digital therapeutics development, with its evidence generation and quality systems, applies. As with any serious health product, these regulatory questions should be settled early, because they shape the entire build.
Building It Right: A Development Approach
Bringing the ethics, the psychology, and the compliance together, the through-line of building a pediatric oncology adherence app is that it must be designed with and for children and their families, not merely at them.
The most effective pediatric health apps are co-created with their users. Re-Mission was built with input from more than a hundred young cancer patients, and the broader research consistently shows that involving children, parents, and clinicians throughout design produces tools that are more relevant, more usable, and more effective. This participatory approach is also an ethical safeguard, because designing alongside the children who will use the app, and the clinicians who care for them, makes it far harder to drift into mechanics that serve metrics over patients. A capable healthcare app development partner should treat this co-design process, along with clinical and psychological expertise, as central rather than optional.
That approach should run through the whole lifecycle. Ground the design in behavioral theory and clinical input from the start. Co-create with children and families. Build the ethical principles of autonomy, competence, and relatedness into the mechanics rather than adding engagement features and hoping they are harmless. Engineer HIPAA and COPPA compliance in from the first sprint. And validate the app not just on engagement metrics, which can be misleading, but on the outcomes that actually matter: adherence, understanding, and the wellbeing of the child. An app that scores high on time-in-app but has quietly become a source of stress or compulsion for a sick child has failed, no matter what the engagement dashboard says.
The Opportunity, and the Responsibility
Pediatric oncology presents a rare and meaningful opportunity for well-built software. The problem is enormous and the stakes could not be higher: adherence below a narrow threshold measurably raises a child’s risk of relapse, nearly half of young patients fall short of it, and the reasons are behavioral and developmental in exactly the ways thoughtful design can address. There is real clinical evidence, including a rigorous randomized trial, that gamification can move the needle on chemotherapy adherence in young patients. The potential to help children survive their cancer by helping them stay on treatment is genuinely inspiring.
But this is also a domain that demands more ethical care than almost any other in digital health, precisely because the same psychological mechanisms that make gamification effective are the ones that dark patterns exploit, and because the users are children who are both developmentally and medically vulnerable. The line between engagement that serves a child and mechanics that exploit them is not a matter of taste. It is a matter of respecting a young person’s autonomy, competence, and connection, and of refusing to trade their wellbeing for an engagement metric. Get that wrong, even with good intentions, and you build something that manipulates frightened children. Get it right, and you build something that genuinely helps them.
That is the hard part, and it is the part worth getting right: the clinical grounding, the psychological literacy, and the ethical discipline to design gamification that builds a child up rather than hooking them, all atop rigorous, child-appropriate privacy and compliance. If you are building a pediatric health app and want a partner who takes both the engagement and the ethics seriously, the team at Dogtown Media builds thoughtful, compliant health applications from the ground up.
Frequently Asked Questions
Why is medication adherence such a critical issue in pediatric cancer specifically?
Because in pediatric cancer, adherence is directly tied to survival, not just symptom control. In childhood acute lymphoblastic leukemia, patients take a daily oral chemotherapy drug during a maintenance phase that can last 18 to 30 months, and research from the Children’s Oncology Group found that adherence below 95% was associated with a 2.7-fold higher risk of relapse. The margin is unforgiving, and a landmark trial found that 44% of young patients fell below that threshold. Improving adherence in this context can literally save a child’s life, which is why it draws such serious attention.
Does gamification actually improve medication adherence, or is it just hype?
There is real evidence that it can work, but it is not a guaranteed solution. Systematic reviews have found that gamified adherence apps improve outcomes across various chronic conditions, and in pediatric oncology specifically, a randomized controlled trial of the video game Re-Mission showed improved chemotherapy adherence measured objectively through blood tests rather than self-report. That said, the evidence is nuanced, with one review finding that 59% of gamification studies showed positive effects while 41% were mixed or neutral, and much of the research is short-term. Gamification works when it is well designed and grounded in behavioral theory, and disappoints when it is a superficial layer of points and badges.
What exactly are dark patterns, and why are they worse for children?
Dark patterns are design tricks that manipulate users into choices they would not otherwise make if they fully understood the situation or had a genuine choice. In games they include tactics like artificial grinding, disguised costs, social pressure, and the exploitation of emotional states. Children are especially vulnerable because their executive functioning is still developing, which makes them more impulsive, their abstract thinking is immature, which makes it hard to see through manipulative design, and their strong need for peer acceptance makes social-pressure tactics potent. The FTC has taken enforcement action over dark patterns, including a $245 million penalty against the maker of Fortnite, with specific concern for their effects on children.
How do you tell the difference between ethical gamification and exploitative gamification?
The clearest test comes from Self-Determination Theory, which identifies three basic psychological needs: autonomy, competence, and relatedness. Ethical gamification supports these needs, giving the child genuine choice, helping them build real capability and understanding, and connecting them to supportive people, which produces durable, internalized motivation. Exploitative gamification bypasses these needs and coerces behavior through external pressure, guilt, loss aversion, or compulsion loops, which produces fragile short-term compliance and can even undermine a child’s own motivation through the overjustification effect. If a mechanic relies on pressure, shame, or manufactured anxiety, it is on the wrong side of the line.
What is the overjustification effect and why does it matter here?
The overjustification effect is a well-documented phenomenon in which offering tangible, expected rewards for an activity can reduce a person’s intrinsic motivation to do it, by shifting their perceived reason from internal to external. In a pediatric oncology app, this is a real hazard, because a reward system designed carelessly could make a child take their medication to earn prizes rather than to protect their own health, which is a fragile foundation. The better goal is to help the child build their own durable commitment to their treatment, using the app as a supportive scaffold rather than a permanent external motivator.
What privacy and regulatory rules apply to a pediatric oncology app?
Several overlapping ones. Any app handling protected health information must comply with HIPAA, which requires encryption, strong authentication, access controls, and audit logging. Because the users are children, the app also falls under COPPA, the Children’s Online Privacy Protection Act, which imposes strict requirements around parental consent and the handling of data from children under 13. Data minimization is essential. And if the app’s functions extend into diagnosing or actively managing the disease, it may qualify as a regulated medical device subject to FDA oversight. These questions should be resolved early because they shape the entire product.
What is the single most important principle when building one of these apps?
Design with genuine respect for the child, and let that principle govern every mechanic. Concretely, that means grounding the design in behavioral theory, co-creating it with children, families, and clinicians rather than imposing it on them, building in support for the child’s autonomy, competence, and relatedness rather than exploiting their impulses, and measuring success by adherence and wellbeing rather than raw engagement. The goal is to help a child build a durable commitment to a treatment that protects their life, not to hook them on an app. Keeping that goal central is what separates a legitimate medical tool from an engagement product in a medical costume.
